Elisabetta Toso
Research Subjects
Elisabetta Toso has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Davide Sardi
Division of Cardiology, Department of Internal Medicine, Cardinal Massaia Hospital, Asti, Italy
2 shared publications- Fiorenzo Gaita
Department of Medical Sciences, University of Turin, Turin, Italy
2 shared publications Lucia Garberoglio
Division of Cardiology, Department of Medical Sciences, San Giovanni Battista Hospital, University of Turin, Turin, Italy
2 shared publicationsAlberto Battaglia
Cardiology Division, Department of Internal Medicine, San Giovanni Battista Hospital, University of Turin, Italy
1 shared publication- Alberto Battaglia
CIC-IT 1433, INSERM, Universite de Lorraine and CHRU Nancy, Nancy France
1 shared publication Alessandro Blandino
Cardiology Division, Department of Internal Medicine, San Giovanni Battista Hospital, University of Turin, Italy
1 shared publication
Latest Publications
- 1 May 2014
- Published by Elsevier in Heart Rhythm
- Vol. 11 (5) , 777-782
Long-term progression from paroxysmal to permanent atrial fibrillation following transcatheter ablation in a large single-center experience
- 1 May 2014
- Published by Elsevier in Heart Rhythm
- Vol. 11 (5) , 777-782
Long-term progression from paroxysmal to permanent atrial fibrillation following transcatheter ablation in a large single-center experience
- 3 July 2012
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 35 (9) , 1126-1134
Electrical Cardioversion of Persistent Atrial Fibrillation: Acute and Long‐Term Results Stratified According to Arrhythmia Duration
Background: Current definition of persistent atrial fibrillation (PAF) enrolls a heterogeneous population with different atrial fibrillation (AF) exposure and degree of atrial substrate. Study aims were to evaluate acute and long‐term results of electrical cardioversion (ECV) and to identify temporal cutoff of previous AF exposure to reclassify PAF in subgroups with different chance of sinus rhythm (SR) maintenance. Methods: Five hundred twenty‐one patients (66% men; age 69 ± 10 years) with PAF undergoing ECV, were divided in four groups according to AF duration at the time of ECV: group A with AF ≤2 months (141 patients); group B with AF >2 and ≤4 months (176 patients); group C with AF >4 and ≤6 months (89 patients); and group D with AF >6 months and Results: There was no difference in term of acute success among groups (98.5% vs 97.1% vs 98.9% vs 96.5%, respectively, P = 0.95). At 5‐year follow‐up, 198 (41%) patients were in SR: 50% in group A, 44% in group B, 42% in group C, and 25% in group D (P < 0.001). At the multivariate analysis, previous ECV (hazard ratio [HR] 1.55, P < 0.001), left atrium enlargement (HR 1.39, P = 0.013), and AF duration >6 months at time of procedure (HR 1.59, P = 0.001) independently predict ECV failure. Conclusion: ECV is associated with high acute success rate and low complications rate. Long‐term results are strongly related with AF duration at time of ECV: a cutoff of >6 months helps in selecting patients that can take greater advantage of the procedure. (PACE 2012; 35:1126–1134)
- 3 July 2012
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 35 (9) , 1126-1134
Electrical Cardioversion of Persistent Atrial Fibrillation: Acute and Long‐Term Results Stratified According to Arrhythmia Duration
Background: Current definition of persistent atrial fibrillation (PAF) enrolls a heterogeneous population with different atrial fibrillation (AF) exposure and degree of atrial substrate. Study aims were to evaluate acute and long‐term results of electrical cardioversion (ECV) and to identify temporal cutoff of previous AF exposure to reclassify PAF in subgroups with different chance of sinus rhythm (SR) maintenance. Methods: Five hundred twenty‐one patients (66% men; age 69 ± 10 years) with PAF undergoing ECV, were divided in four groups according to AF duration at the time of ECV: group A with AF ≤2 months (141 patients); group B with AF >2 and ≤4 months (176 patients); group C with AF >4 and ≤6 months (89 patients); and group D with AF >6 months and Results: There was no difference in term of acute success among groups (98.5% vs 97.1% vs 98.9% vs 96.5%, respectively, P = 0.95). At 5‐year follow‐up, 198 (41%) patients were in SR: 50% in group A, 44% in group B, 42% in group C, and 25% in group D (P < 0.001). At the multivariate analysis, previous ECV (hazard ratio [HR] 1.55, P < 0.001), left atrium enlargement (HR 1.39, P = 0.013), and AF duration >6 months at time of procedure (HR 1.59, P = 0.001) independently predict ECV failure. Conclusion: ECV is associated with high acute success rate and low complications rate. Long‐term results are strongly related with AF duration at time of ECV: a cutoff of >6 months helps in selecting patients that can take greater advantage of the procedure. (PACE 2012; 35:1126–1134)